93 related articles for article (PubMed ID: 7496335)
1. Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes.
Ulbig MW; Wolfensberger TJ; Hiscott P; Ationu A; Carter ND; Gregor ZJ
Ger J Ophthalmol; 1995 Sep; 4(5):264-8. PubMed ID: 7496335
[TBL] [Abstract][Full Text] [Related]
2. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
4. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
[TBL] [Abstract][Full Text] [Related]
5. [Posterior hyaloid membrane as structural base of growth of neovascular tissue in proliferative diabetic retinopathy].
Krasnov MM; Sdobnikova SV; Fedorov AA; Stoliarenko GE
Vestn Oftalmol; 1998; 114(3):16-20. PubMed ID: 9720391
[TBL] [Abstract][Full Text] [Related]
6. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
Heidenkummer HP; Kampik A
Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
[TBL] [Abstract][Full Text] [Related]
7. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
9. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
[TBL] [Abstract][Full Text] [Related]
10. Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy.
Dong Z; Kase S; Ando R; Fukuhara J; Saito W; Kanda A; Murata M; Noda K; Ishida S
Retina; 2012 Jun; 32(6):1190-6. PubMed ID: 22371118
[TBL] [Abstract][Full Text] [Related]
11. Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.
Bergman PB; Moravski CJ; Edmondson SR; Russo VC; Bach LA; Wilkinson-Berka JL; Werther GA
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2708-15. PubMed ID: 16043842
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor 1 receptors are increased in estrogen-induced kidney tumors.
Narayan S; Roy D
Cancer Res; 1993 May; 53(10 Suppl):2256-9. PubMed ID: 8485711
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
[TBL] [Abstract][Full Text] [Related]
14. [The specificity of the ultrastructural pattern of neoplastic vessels of the retina in diabetic retinopathy].
Sdobnikova SV; Chekmareva IA; Fedorov AA; Mazurina NK; Kochetkova EA
Vestn Oftalmol; 2005; 121(1):25-9. PubMed ID: 15759844
[TBL] [Abstract][Full Text] [Related]
15. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
16. Proliferation and activation of vascular endothelial cells in epiretinal membranes from patients with proliferative diabetic retinopathy. An immunohistochemistry and clinical study.
Tang S; Le-Ruppert KC; Gabel VP
Ger J Ophthalmol; 1994 May; 3(3):131-6. PubMed ID: 7518716
[TBL] [Abstract][Full Text] [Related]
17. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
18. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
Gacka M; Adamiec J
Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.
Ishida S; Shinoda K; Kawashima S; Oguchi Y; Okada Y; Ikeda E
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1649-56. PubMed ID: 10845581
[TBL] [Abstract][Full Text] [Related]
20. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
